Schulz E, Mödder B, Fisher J W
Contrib Nephrol. 1978;13:69-80. doi: 10.1159/000402135.
ESF deficiency is probably not a major contributing factor in the early stages of the anemia of renal insufficiency. Serum ESF titers are lower in advanced renal failure when compared to that of nonuremic anemic subjects suffering from equivalent anemia. With increasing renal insufficiency a relative ESF deficiency gains increasing importance as a pathogenic factor in reduced erythropoiesis. Kidneys without excretory function may still be erythropoietically effective, since a further increase in the anemia occurs after bilateral nephrectomy. However, a basal erythropoiesis is still maintained by extrarenal ESF production, which is also enhanced by hypoxia. ESF deficiency is compensated after successful renal transplantation. A decreased response of the bone marrow to ESF may be another factor contributing to the hypoproliferative state of erythropoiesis in uremia. As demonstrated in a chronic uremic rabbit model there may be a blockade of further differentiation of the erythroid precursors. The relationship of this blockade in differentiation to the inhibitor of heme synthesis is not clear.
促红细胞生成素(ESF)缺乏可能不是肾功能不全贫血早期的主要促成因素。与患有同等程度贫血的非尿毒症贫血患者相比,晚期肾衰竭患者的血清ESF滴度较低。随着肾功能不全的加重,相对ESF缺乏作为红细胞生成减少的致病因素变得越来越重要。没有排泄功能的肾脏仍可能具有促红细胞生成作用,因为双侧肾切除术后贫血会进一步加重。然而,肾外ESF的产生仍能维持基础红细胞生成,缺氧也会增强这种产生。肾移植成功后,ESF缺乏得到补偿。骨髓对ESF反应降低可能是导致尿毒症时红细胞生成低增殖状态的另一个因素。正如在慢性尿毒症兔模型中所证明的,红系前体细胞的进一步分化可能存在阻断。这种分化阻断与血红素合成抑制剂之间的关系尚不清楚。